바이오테크놀러지, 의약품 개발, 약물전달 시스템용 나노입자

Highlights:

The global nanoparticles in biotechnology, drug development, and drug delivery systems market should reach $156.8 billion by 2028 from $102.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.8% for the forecast period of 2023 to 2028.

Drug delivery systems segment of the global nanoparticles in biotechnology, drug development, and drug delivery systems market is expected to grow from $53.8 billion in 2023 to $75.1 billion in 2028 at a CAGR of 6.9% for the forecast period of 2023 to 2028.

Diagnostics segment of the global nanoparticles in biotechnology, drug development, and drug delivery systems market is expected to grow from $2.4 billion in 2023 to $4.2 billion in 2028 at a CAGR of 11.8% for the forecast period of 2023 to 2028.

Report Scope:

The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and formulation, drug delivery systems, and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections.

The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.

Market figures are based on revenues at the manufacturer level and are projected in dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded markets for existing products, and other factors affecting the market.

The study is arranged to offer an overview of existing nanoparticle technology and drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic regions and countries. Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.

Figures are reported in U.S. dollars and each case reflects currency fluctuations within the performance of revenue change. Revenue figures do not account for variations in local currencies. All market share data presented is on a global basis unless specifically mentioned.

Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes:

• 25 data tables and 40 additional tables
• An updated overview and in-depth analysis of the global markets for nanoparticles in biotechnology, drug development and drug delivery systems
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for nanoparticles in biotechnology, drug development and drug delivery systems market, and corresponding market share analysis by technology, application and region
• Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
• In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
• Discussion on the role of nanotechnology in the COVID-19 vaccine production, mechanism of action, components and methods in vaccine design for COVID-19 and challenges for vaccine disruptions
• Review of the leading and emerging drug products for each nanoparticle type, clinical trial landscape for various candidate nanodrugs, status of approvals of drugs in each segment, and penetration of technologies and research initiatives within the ecosystem
• Updated information on patents and patent applications on nanoparticles in biotechnology, drug development and drug delivery systems, and related scientific publications
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performances, and segmental revenues
• Descriptive company profiles of the leading global players in the market, including Bristol-Myers Squibb Co., Camurus, GlaxoSmithKline PLC, Merck & Co. Inc. and Novartis AG

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Report?
• Scope of Report
• Methodology
• Market Estimate
• Information Sources
• Primary Research
• Secondary Research
• Geographic Breakdown
• Market Segmentation
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

• Introduction to Nanoparticles
• Liposomes
• Quantum Dots
• Dendrimers
• Macromolecule Nanoparticles
• Brief History of Nanoparticles
• Nanoparticles in Biotechnology
• Nanoparticles in Drug Development
• Nanoparticles in Drug Delivery Systems
• Nanoparticles in Diagnostic Imaging
• Major Players in the Nanoparticle Drug Delivery Field
• Major Nanoparticle/Nanocrystal Drugs
• Market Dynamics
• Drivers
• Restraints
• PESTEL Analysis
• Regulatory Landscape
• U.S.
• Europe
• India
• Emerging Technologies in Nanoparticles
• Gadolinium-Neutron Capture Therapy (Gd-NCT) for Glioblastoma Multiforme (GBM) Treatment
• Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to treat Liver Fibrosis

Chapter 4 Role of Nanotechnology in COVID-19 Vaccine Production

• Introduction
• Fight Against Novel Coronavirus
• Structure of COVID-19 and Penetration
• Challenges for COVID-19 Vaccines
• Components and Methods in the Design of Vaccines
• Antigen
• Adjuvant
• Nanoparticle/Nanocarrier
• Device
• Next-Generation Vaccines Enabled Through Advances in Nanotechnology
• Conclusion on Nanotechnology Use Against COVID-19

Chapter 5 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology

• Technology Overview
• Liposomes
• Polymeric Micelles
• Dendrimers
• Others

Chapter 6 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application

• Biotechnology
• Drug Development and Formulation
• Drug Delivery Systems
• Diagnostic Imaging

Chapter 7 Structure of Nanoparticles

• Adoption of Nanoparticles in Applied Markets
• Liquid Crystals
• Liquid Carriers
• Liposomes
• Dendrimers
• Chitosan and Alginate
• Nanocrystals
• Quantum Dots
• Application of Nanoparticles to Drugs Delivered

Chapter 8 Production of Nanoparticles

• Methods of Nanoparticle Formation
• Self-Assembly Production
• Methods of Stabilization
• Methods of Drug Introduction
• Polymeric Nanoparticles
• Micelles
• Liposomes
• Gold and Silicon Nanoparticles
• Dendrimers
• Methods for Loading Biological Molecules into Nanoparticles
• Nanocrystal Drugs
• Problems with Large-Scale Nanoparticle Production

Chapter 9 Nanoparticles in Biotechnology

• Research and Development
• Stem Cell Research
• Cellular Repair
• Paramagnetic and Superparamagnetic Nanoparticles
• Biosensors and Quantum Dots
• Nanoparticle Research Collaborative Programs

Chapter 10 Nanoparticles in Drug Development and Formulation

• Bio Separations
• Rapid Drug Analysis
• Removal of Impurities and Toxins
• Using Nanoparticles to Incorporate Insoluble Drugs
• Gold and Silver Nanoparticles in Biomedicine
• DNA Nanoparticle Development of DNA-Specific Drugs

Chapter 11 Nanoparticles in Drug Delivery Systems

• Nanoparticles in Drug Delivery Applications
• Designing a Nanoparticle Drug Delivery System
• Nanoparticle Drug Stability
• Size Homogeneity of Nanoparticle Preparations
• Drug Loading of Nanoparticles
• Drug Release from Nanoparticles
• External Triggers for Releasing Drugs from Nanoparticles
• Binding/Incorporation of Biomolecules to Nanoparticles
• Nanoparticle Toxicity
• Large-Scale Manufacturing
• Methods of Administration of Nanoparticle Drugs
• Oral Administration
• Injection Administration
• Transdermal Patch
• Implantation Administration
• Inhalation Administration
• Nanoparticles Suitable for Drug Delivery Systems
• Lipid-Based Nanoparticles
• Micelle Nanoparticles
• Dendrimer Nanoparticles
• Polymeric Nanoparticles
• Metal-Based Nanoparticles
• Biological Macromolecule Nanoparticles
• Nanocrystals
• Nanoparticle Drug Delivery Systems Now Available
• Antibiotic Nanoparticles
• Anti-Tumor and Small Molecule Delivery by Nanoparticle
• Release of Anti-Cancer Drugs from Nanoparticles
• Biomacromolecules Delivered by Nanoparticles
• Nanoparticles Coating for Drug Delivery Systems
• Removal of Nanoparticles from the Body

Chapter 12 In Vitro and In Vivo Diagnostic Imaging

• In Vitro Imaging
• Nanoparticles in Diagnostic Imaging

Chapter 13 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region

• Market Overview and Discussion
• North America
• Europe
• Asia-Pacific
• Rest of the World
• South America
• Middle East and Africa

Chapter 14 Competitive Landscape

• Nanoparticle Drug Delivery Systems and Products
• Major Players in Nanoparticle Drug Delivery Systems
• Company Pipelines for Nanoparticle Drug Delivery
• Drivers of Nanoparticle Products and Marketing
• Limiters of Nanoparticle Product Development and Marketing

Chapter 15 Patents, Licensing, Mergers and Acquisitions

• Recent Licensing Activity, Mergers, and Acquisition
• Recent Deals
• Nanoparticle Patents

Chapter 16 Company Profiles

• BRISTOL-MYERS SQUIBB CO.
• CAMURUS AB
• CERAMISPHERE HEALTH PTY LTD.
• CYTIMMUNE SCIENCES
• GILEAD SCIENCES INC.
• GLAXOSMITHKLINE PLC
• HOFFMANN-LA ROCHE INC.
• MERCK & CO. INC.
• NANOCARRIER CO., LTD.
• NOVARTIS AG